Effects of a constant-rate infusion of dexmedetomidine on the minimal alveolar concentration of sevoflurane in ponies.
Authors: Gozalo-Marcilla M, Hopster K, Gasthuys F, Hatz L, Krajewski A E, Schauvliege S
Journal: Equine veterinary journal
Summary
# Editorial Summary: Dexmedetomidine Reduces Sevoflurane Requirements in Ponies Whilst dexmedetomidine constant-rate infusions have been used clinically in equine anaesthesia to support cardiovascular stability and improve recovery quality, whether this agent reduces inhalant anaesthetic requirements—a phenomenon well-documented in other species—remained unproven in equines. Researchers administered a dexmedetomidine bolus (3.5 µg/kg) followed by a CRI of 1.75 µg/kg/h to six ponies undergoing sevoflurane anaesthesia, using electrical skin stimulation and a bracketing technique to determine minimal alveolar concentration (MAC) values; saline controls were performed in crossover fashion with a three-week washout period. The dexmedetomidine protocol produced a striking 53% reduction in sevoflurane MAC, lowering requirements from 2.42% to 1.07%—a magnitude of sparing effect comparable to that seen in other species. This substantial reduction in volatile anaesthetic exposure during dexmedetomidine co-anaesthesia has direct implications for practitioners: lower sevoflurane concentrations reduce metabolic burden, decrease emergence delirium risk, and may improve haemodynamic stability during longer procedures, though clinicians should remain cautious about titrating inhalant agents downward until further work clarifies the effects on analgesia and cardiovascular variables during actual surgical stimulation.
Read the full abstract on PubMed
Practical Takeaways
- •Using dexmedetomidine infusion during sevoflurane anaesthesia can reduce required inhalant gas concentrations by approximately half, potentially decreasing anaesthetic waste and cost
- •The combination of dexmedetomidine CRI with sevoflurane maintains cardiovascular stability while allowing lower volatile anaesthetic requirements
- •Practitioners can utilize dexmedetomidine as an anaesthetic adjunct to improve inhalational anaesthesia efficiency and facilitate smoother recoveries
Key Findings
- •Dexmedetomidine CRI at 1.75 µg/kg/h reduced sevoflurane MAC by 53 ± 15%
- •Sevoflurane MAC decreased from 2.42 ± 0.55% to 1.07 ± 0.21% with dexmedetomidine treatment
- •Dexmedetomidine demonstrates significant inhalant anaesthetic sparing effects in ponies